2U.S.Ubile Health Service U.S.Updated US.Public Health Service Guidelines for the Management of Oec.upational Exposures to HBV,HCV,and HIV and Recommendations for Postexposure Prophylaxis.MMWR Recomm Rep,2001,50:1-52.
5Mitsui T,lwano K,Masuko K,et at.Hepatitis C virus infeetion in medical personoel after ncedlestiek accident.Hepatology,1992,16:1109-1114.
6Alter MJ.The epidemiology of acute and chronic hepatitis C.Clin Liver Dis,1997,1:559-568.
7Puro V,Petrosillo N,Ippolito G.Italian Study C,roap on Occupational Risk of HIV and Other Bloodborne Infections.Risk of hepatitis C seroconversion after occupational exposure in health care workers.Am J Infect Control,1995,23:273-277.
8Ippolito G,Pure V,Petrosillo N,et al.Simultaneous infection with HIV and hepatitis C virus following occupational conjunctival blood exposure.JAMA,1998,280:28.
9Davis GL,Lan JY,Urdea MS,et al.Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method:definition of optimal conditions for specimen collection and chnical application in interferontreated patients.Hepatology,1994,19:1337-1341.
10Favero MS,Alter MJ.The reemergence of hepatitis B virus infection in hemodialysis centers.Semin Dial,1996,9:373-374.
二级参考文献31
1Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
2Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
3Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
4Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
5Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
6Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.
7Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review[J]. Hepatology, 2002, 36(5 Suppl 1 ):S135 - S144.
8Di Ciomm no V, Russo P, Rava L, etal. Interferon alpha in the treatment of chronic hepatitis C in children: a mmeta- analysis[J] .J Viral Hepat,2003,10:210 - 214.
9Fabrizi F, Dulai G, DixitV, et al. Meta- analysis: interfeorn for the treatment of chronic hepatitis C in dialysis patients[J] .Aliment Phamacol Ther, 2003,18:1071 - 1081.
10National Institute of Health Consensus Development Conference Panel Statenent. Management of hepatitis C[J].Hepatology, 2002,36(5 Suppl 1):S3- S20.
9U.S.Ubilc Health Service U.S.Updated US.Pablic Heaith Service Guide-lines for the Management of Occupational Exposures to HBV,HCV,and HIV and Recommendations for Postexposure Prophyaxis.M M W R Recomm REP,2001:501-52.
